Log in to save to my catalogue

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7579719

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression

About this item

Full title

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2020-10, Vol.24 (20), p.12032-12043

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Multiple mechanisms contribute to the survival and growth of metastatic castration‐resistant prostate cancer (mCRPC) cells without androgen, including androgen receptor splice variants (AR‐V) and de novo intratumoral androgen synthesis. AKR1C3 is a critical androgenic enzyme that plays different roles in mCRPC, such as an EMT driver or AR coactivat...

Alternative Titles

Full title

The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7579719

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7579719

Other Identifiers

ISSN

1582-1838

E-ISSN

1582-4934

DOI

10.1111/jcmm.15831

How to access this item